"Health Years in Total (HYT): A New Health Objective Function for Cost-effectiveness Analysis"
Anirban Basu, PhD, MS, is a health economist and a statistician specializing in research on comparative and cost-effectiveness analyses, causal inference methods, program evaluation, and outcomes research. Anirban is Director of The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute at the University of Washington, Seattle, with appointments in the departments of Pharmacy, Health Services, and Economics at the university. He is a Faculty Research Fellow at the National Bureau of Economic Research, and a Fellow of the American Statistical Association. He was one of the panelists for the Second Panel on Cost-Effectiveness Analysis in Health and Medicine. Anirban’s research interests include heterogeneity in clinical and economic outcomes, micro behavior with respect to heterogeneous information, and the value of individualized care. He received his PhD in Public Policy (Health Economics Specialization) from The University of Chicago and an MS in Biostatistics from the University of North Carolina at Chapel Hill.
Anirban will present a new metric for effectiveness for CEA, Health Years in Total (HYT), that overcomes both this specific distributional issue raised by QALY and the efficiency challenges of EVL.. The HYT framework fundamentally separates life-expectancy changes and quality of life changes in an additive scale. The seminar will examine conceptual and theoretic arguments for use of HYT and illustrate their performance against QALYs and EVL. Methods to calculate HYT in a CEA model, to derive CEA thresholds for HYT corresponding to the QALY-based thresholds in the US and policy implications for the use of HYT using recently published technology evaluations will also be presented.